Lisa Horvath

17PUBLICATIONS
351CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsNeurology and neuromuscular diseasesDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Mar 25, 2026
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Eva Apostolov, Daniel L Roden, Holly Holliday

|Mar 06, 2026
A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.

Barak Talmor, Stefano Marastoni, Brandon Lau

|Jan 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?

Kim Edmunds, Shiksha Arora, Sri Teppala

Pageof 3

Frequent Collaborators

5 joint publications

Hui-Ming Lin

3 joint publications

Anthony M Joshua

3 joint publications

Peter J Meikle

3 joint publications

James G Kench